TNF Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
TNF Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2023.
  • TNF Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $299K, a 1401% increase year-over-year.
  • TNF Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.96M, a 479% increase from 2022.
  • TNF Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $339K, a 277% increase from 2021.
  • TNF Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $90K.
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.96M +$1.62M +479% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $339K +$249K +277% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $90K Jan 1, 2021 Dec 31, 2021 10-K 2022-03-31
2017 $5.46K Jan 1, 2017 Dec 31, 2017 10-Q 2018-07-13
2015 $32K -$518K -94.2% Jan 1, 2015 Dec 31, 2015 10-K 2016-03-30
2014 $550K Jan 1, 2014 Dec 31, 2014 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.